Showing results (81-90 of 120) with videos related to
Sort By:
Pageof 12
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sitesS Wonnacott, S Jackman, K L Swanson, et al.Journal of Neurochemistry|March 7, 1998
Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slicesS A Kaiser, L Soliakov, S C Harvey, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1991
Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sitesK L Swanson, R S Aronstam, S Wonnacott, et al.Psychopharmacology|January 1, 1993
Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonistH S Garcha, P Thomas, C E Spivak, et al.Brain Research|July 9, 1993
Differential cholinergic and non-cholinergic actions of acetylcholinesterase in the substantia nigra revealed by fasciculin-induced inhibitionF Dajas, R Silveira, G Costa, et al.The Journal of Biological Chemistry|June 13, 2000
Do structural deviations between toxins adopting the same fold reflect functional differences?A Ricciardi, M H le Du, M Khayati, et al.FEBS Letters|September 17, 1990
Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sitesJ M Ward, V B Cockcroft, G G Lunt, et al.Brain Research|November 24, 1998
Hydroxyl radical production in the substantia nigra after 6-hydroxydopamine and hypoxia-reoxygenationF A Dajas-Bailador, A Martinez-Borges, G Costa, et al.Heart (British Cardiac Society)|January 29, 2000
Antianginal and anti-ischaemic efficacy of tedisamil, a potassium channel blockerK M Fox, J R Henderson, J C Kaski, et al.Biochemical Pharmacology|February 4, 1992
Homoanatoxin: a potent analogue of anatoxin-AS Wonnacott, K L Swanson, E X Albuquerque, et al.Pageof 12